Nomura Research Institute, Ltd.
NRILY · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $2,784 | $2,445 | $1,854 | $2,367 |
| - Cash | $169 | $174 | $129 | $116 |
| + Debt | $271 | $299 | $238 | $250 |
| Enterprise Value | $2,887 | $2,569 | $1,963 | $2,502 |
| Revenue | $765 | $737 | $692 | $612 |
| % Growth | 3.8% | 6.4% | 13.2% | – |
| Gross Profit | $275 | $261 | $240 | $216 |
| % Margin | 36% | 35.4% | 34.6% | 35.3% |
| EBITDA | $189 | $167 | $155 | $145 |
| % Margin | 24.7% | 22.7% | 22.3% | 23.6% |
| Net Income | $94 | $80 | $76 | $71 |
| % Margin | 12.3% | 10.8% | 11% | 11.7% |
| EPS Diluted | 163.56 | 136.84 | 128.88 | 120.34 |
| % Growth | 19.5% | 6.2% | 7.1% | – |
| Operating Cash Flow | $130 | $142 | $119 | $98 |
| Capital Expenditures | -$50 | -$50 | -$55 | -$43 |
| Free Cash Flow | $81 | $92 | $64 | $55 |